V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012130 | 330003547 | null | 25.8 | Disease modification (D) | 2015-09-13 | 2015-09-23 | CNS GCT II Germinoma - Ifos Etop | 2 | N | 330004842 | NOT MATCHED |
| 330012131 | 330003550 | 1.58 | 46.1 | Curative (C) | 2015-05-02 | 2015-05-13 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330004954 | CISPLATIN + RT |
| 330012132 | 330003552 | 0 | 19 | Curative (C) | 2017-02-18 | 2017-07-09 | NB HRNBL-1 ch14.18/CHO only (trial) | Y | null | 330004963 | NOT MATCHED |
| 330012133 | 330003553 | 0 | 15 | Adjuvant (A) | 2017-03-25 | 2017-03-29 | CNS GCT II Non Germin - Std PEI | N | null | 330004971 | NOT MATCHED |
| 330012134 | 330003556 | null | 104.7 | null | 2018-04-16 | 2018-04-23 | CISPLATIN + RT | N | Y | 330004985 | CISPLATIN + RT |
| 330012135 | 330007915 | null | 57.8 | Curative (C) | 2014-08-21 | 2014-08-24 | Mifamurtide weeks 1-12 | null | null | 330005102 | MIFAMURTIDE |
| 330012136 | 330010305 | 1.82 | 85 | Neo-adjuvant (N) | null | 2017-09-01 | DOXORUBICIN | N | null | 330005138 | DOXORUBICIN |
| 330012137 | 330003579 | 1.77 | 82.6 | Curative (C) | 2014-02-12 | 2014-10-21 | Trial Unspecified | null | null | 330005201 | TRIAL |
| 330012138 | 330003586 | 1.57 | 73.3 | Disease modification (D) | 2013-09-15 | 2013-09-29 | Trial Unspecified | N | Y | 330005221 | TRIAL |
| 330012139 | 330003591 | 1.82 | 67 | Palliative (P) | 2018-04-18 | 2018-04-25 | LI-1 TRIAL | N | N | 330005262 | TRIAL |
| 330012140 | 330007930 | null | 86 | Adjuvant (A) | null | 2015-10-26 | MIFAMURTIDE | null | null | 330005264 | MIFAMURTIDE |
| 330012141 | 330003602 | 1.81 | 16.3 | Curative (C) | 2014-09-19 | 2014-09-30 | EW EuroEwing 2012 Arm A VAI | Y | null | 330005305 | TRIAL |
| 330012142 | 330003607 | 1.64 | null | Neo-adjuvant (N) | 2019-04-16 | 2019-05-01 | EW EuroEwing 2012 Arm A VAI | null | null | 330005315 | TRIAL |
| 330012143 | 330003609 | 1.84 | 58 | Curative (C) | 2014-06-10 | 2014-06-16 | Cisplatin | 02 | N | 330005325 | CISPLATIN |
| 330012144 | 330003611 | 1.82 | 62 | Adjuvant (A) | null | 2015-11-30 | METHOTREXATE | null | null | 330005334 | METHOTREXATE |
| 330012145 | 330003614 | 0 | 86.8 | Neo-adjuvant (N) | null | 2015-09-05 | METHOTREXATE | N | null | 330005358 | METHOTREXATE |
| 330012146 | 330003617 | null | null | Curative (C) | 2015-07-05 | 2015-09-26 | Trial Unspecified | N | null | 330005388 | TRIAL |
| 330012147 | 330003621 | 1.61 | 73.9 | Adjuvant (A) | 2016-01-22 | 2016-07-12 | DOXORUBICIN | Y | N | 330005418 | DOXORUBICIN |
| 330012148 | 330003627 | 1.68 | 54 | Neo-adjuvant (N) | 2016-01-14 | 2016-06-30 | Mifamurtide weeks 13-36 | null | null | 330005461 | MIFAMURTIDE |
| 330012149 | 330003632 | 1.82 | 62 | Neo-adjuvant (N) | 2018-02-20 | 2018-03-23 | METHOTREXATE | null | null | 330005520 | METHOTREXATE |
| 330012150 | 330003646 | 1.67 | null | Curative (C) | 2016-07-24 | 2016-07-24 | METHOTREXATE | N | Y | 330005587 | METHOTREXATE |
| 330012151 | 330003649 | 0 | 55 | Neo-adjuvant (N) | null | 2018-01-01 | OST Mifamurtide | N | null | 330005616 | MIFAMURTIDE |
| 330012152 | 330003653 | 0 | 49.1 | Adjuvant (A) | null | 2017-08-25 | OST Euramos 1 Closed Trial - A | null | null | 330005625 | DOXORUBICIN |
| 330012153 | 330007971 | 1.73 | 90 | Adjuvant (A) | 2017-05-25 | 2017-07-20 | METHOTREXATE | 01 | N | 330005676 | METHOTREXATE |
| 330012154 | 330003662 | 1.81 | null | null | 2017-09-22 | 2017-10-07 | Cisplatin 7 day | null | Y | 330005682 | CISPLATIN |
| 330012155 | 330003671 | 1.89 | 90 | Curative (C) | 2016-07-06 | 2016-07-06 | MIFAMURTIDE | 2 | N | 330005694 | MIFAMURTIDE |
| 330012156 | 330003678 | 1.7 | 56.8 | Curative (C) | 2017-02-26 | 2017-02-27 | Doxorubicin 75mg/m2 | N | N | 330005702 | DOXORUBICIN |
| 330012157 | 330003684 | 1.81 | 84.1 | Neo-adjuvant (N) | 2017-06-29 | 2017-12-21 | Trial Unspecified | Y | null | 330005732 | TRIAL |
| 330012158 | 330007985 | 1.81 | 73.3 | Palliative (P) | 2017-09-17 | 2017-09-26 | METHOTREXATE | N | Y | 330005735 | METHOTREXATE |
| 330012159 | 330013011 | 1.82 | 50.3 | Neo-adjuvant (N) | 2015-07-24 | 2015-07-26 | Trial Unspecified | Y | N | 330005860 | TRIAL |
| 330012160 | 330003696 | 1.75 | 77 | Curative (C) | 2016-01-19 | 2016-07-11 | Trial Unspecified | N | null | 330005861 | TRIAL |
| 330012161 | 330003699 | 1.62 | null | Curative (C) | 2015-07-06 | 2016-02-08 | METHOTREXATE | N | N | 330005868 | METHOTREXATE |
| 330012162 | 330010337 | 1.55 | 87 | Adjuvant (A) | 2016-12-24 | 2017-02-21 | Cisplatin | N | N | 330005885 | CISPLATIN |
| 330012163 | 330012357 | null | 49.35 | Palliative (P) | 2017-01-29 | 2017-02-14 | Trial Unspecified | N | Y | 330005896 | TRIAL |
| 330012164 | 330003708 | 1.63 | null | Curative (C) | null | 2019-05-31 | MIFAMURTIDE | null | null | 330005922 | MIFAMURTIDE |
| 330012168 | 330003724 | 1.8 | 83 | Curative (C) | 2014-09-16 | 2015-01-10 | METHOTREXATE | 01 | N | 330006003 | METHOTREXATE |
| 330012169 | 330003727 | 1.9 | 48.1 | Curative (C) | 2015-06-20 | 2015-07-15 | DOXORUBICIN | N | Y | 330006006 | DOXORUBICIN |
| 330012170 | 330003732 | 1.81 | 80.7 | Curative (C) | 2016-07-07 | 2016-07-07 | OST Euramos 1 Closed Trial - A | 02 | N | 330006016 | DOXORUBICIN |
| 330012171 | 330003741 | 1.82 | 35.8 | Palliative (P) | null | 2013-11-13 | METHOTREXATE | null | null | 330006058 | METHOTREXATE |
| 330012172 | 330003747 | 1.76 | 72.5 | Adjuvant (A) | 2014-05-04 | 2014-05-04 | EW EuroEwing 2012 Arm B VDC | 1 | N | 330006497 | TRIAL |
| 330012173 | 330008022 | 1.82 | 52.35 | Curative (C) | 2014-09-18 | 2014-09-18 | Trial Unspecified | 02 | N | 330006926 | TRIAL |
| 330012174 | 330003753 | 1.77 | 0 | Curative (C) | 2017-10-22 | 2017-10-30 | Cisplatin | Y | N | 330007189 | CISPLATIN |
| 330012175 | 330003754 | 1.71 | null | Adjuvant (A) | 2013-11-18 | 2013-11-19 | MIFAMURTIDE | 02 | N | 330007195 | MIFAMURTIDE |
| 330012176 | 330003756 | 1.8 | null | Curative (C) | 2016-06-28 | 2016-09-10 | Cisplatin | 02 | N | 330007212 | CISPLATIN |
| 330012178 | 330008030 | 0 | 74.3 | Palliative (P) | null | 2017-03-28 | Cisplatin 7 day | N | null | 330007214 | CISPLATIN |
| 330012179 | 330003761 | 1.86 | 87.4 | Palliative (P) | 2014-07-15 | 2014-07-29 | Trial Unspecified | N | N | 330007218 | TRIAL |
| 330012180 | 330003764 | 1.75 | 60.1 | Neo-adjuvant (N) | null | 2014-05-11 | METHOTREXATE | Y | N | 330007247 | METHOTREXATE |
| 330012181 | 330003769 | 1.79 | 108 | Adjuvant (A) | 2014-11-15 | 2015-02-07 | Cisplatin 7 day | 02 | Y | 330007248 | CISPLATIN |
| 330012182 | 330003771 | null | 79 | Adjuvant (A) | 2016-07-31 | 2016-08-19 | Methotrexate Intermed dose (1g/m2) | N | N | 330007251 | METHOTREXATE |
| 330012183 | 330003772 | 1.77 | 95.7 | Palliative (P) | 2015-06-11 | 2015-08-23 | Cisplatin | Y | N | 330007260 | CISPLATIN |